Showing results (221-230 of 472) with videos related to
Sort By:
Pageof 48
Therapeutic Advances in Cardiovascular Disease|August 14, 2026
Learning curve of two-incision thoracoscopic double valve replacement: Cumulative sum analysis of postoperative outcomes and proficiency in 252 operations from a single high-volume centerQichen Xu, Zheng Xu, Liangwan Chen, et al.Therapeutic Advances in Cardiovascular Disease|February 10, 2011
Antiplatelet therapy and vascular disease: an updateMamta H Buch, Bernard D Prendergast, Robert F StoreyTherapeutic Advances in Cardiovascular Disease|October 23, 2010
Management of dyslipidemia in the elderly populationFreij A Gobal, Jawahar L MehtaTherapeutic Advances in Cardiovascular Disease|October 23, 2010
Renin-angiotensin-aldosterone system blockade in high-risk hypertensive patients: current approaches and future trendsNageshwara Gullapalli, Michael J Bloch, Jan BasileTherapeutic Advances in Cardiovascular Disease|June 26, 2010
Adiponectin gene polymorphisms and their effect on the risk of myocardial infarction and type 2 diabetes: an association study in an Italian populationBenedetta D Chiodini, Claudia Specchia, Francesca Gori, et al.Therapeutic Advances in Cardiovascular Disease|July 28, 2010
Darapladib: an emerging therapy for atherosclerosisMarshall A CorsonTherapeutic Advances in Cardiovascular Disease|August 31, 2010
Efficacy of an olmesartan medoxomil-based treatment algorithm in patients with hypertension and type 2 diabetes: analysis of diurnal blood pressure control as assessed by 24-hour ambulatory blood pressure monitoringDean J Kereiakes, Joel NeutelTherapeutic Advances in Cardiovascular Disease|October 6, 2010
Efficacy and tolerability of olmesartan/amlodipine combination therapy in patients with mild-to-severe hypertension: focus on 24-h blood pressure controlGianfranco Parati, Juan Eugenio Ochoa, Carlos Ramos, et al.Therapeutic Advances in Cardiovascular Disease|November 20, 2010
Efficacy and safety of nebivolol in Hispanics with stage I-II hypertension: a randomized placebo-controlled trialHenry Punzi, Andrew Lewin, Tatjana Lukić, et al.Therapeutic Advances in Cardiovascular Disease|March 17, 2011
Epidemic of cardiometabolic diseases: a Latin American point of viewPatricio Lopez-Jaramillo, Vicente Lahera, Jose Lopez-LopezPageof 48